Letko, Brosseau & Associates’s Amrize AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,941
Closed -$262K – 114
2026
Q2
$262K Hold
4,941
– – ﹤0.01% 96
2026
Q1
$268K Hold
4,941
– – ﹤0.01% 87
2025
Q4
$272K Sell
4,941
-375
-7% -$19.1K ﹤0.01% 88
2025
Q3
$256K Sell
5,316
-268,832
-98% -$13.7M ﹤0.01% 87
2025
Q2
$13.6M Buy
+274,148
New +$13.8M 0.26% 64

Other funds holding AMRZ

Letko, Brosseau & Associates's AMRZ Position: Q3 2026 in Review

Letko, Brosseau & Associates sold out of Amrize (AMRZ) in Q3 2026, closing a stake of 4,941 shares — an estimated $262K sold.

Letko, Brosseau & Associates first reported a position in AMRZ in Q2 2025 and held it in 5 quarters. The position peaked at $13.6M in Q2 2025. 429 funds tracked by Wall St. Rank hold AMRZ as of Q3 2026.

  • Letko, Brosseau & Associates reported no remaining Amrize position as of Q3 2026 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 4,941 Amrize shares in Q3 2026, an estimated $262K.
  • Letko, Brosseau & Associates first reported a position in Amrize in Q2 2025 and held it in 5 quarters.
  • Letko, Brosseau & Associates's Amrize position peaked at $13.6M in Q2 2025.
  • 429 funds tracked by Wall St. Rank held Amrize as of Q3 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2026, filed 6 Nov 2026.